...
首页> 外文期刊>EFSA Journal >Assessment of the application for renewal of authorisation of zinc chelate of hydroxy analogue of methionine for all animal species
【24h】

Assessment of the application for renewal of authorisation of zinc chelate of hydroxy analogue of methionine for all animal species

机译:对所有动物物种甲硫氨酸羟基螯合物授权授权申请的评估

获取原文
           

摘要

The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the application for renewal of authorisation of zinc chelate of hydroxy analogue of methionine (Mintrex?Zn) for all animal species. The FEEDAP Panel has delivered three opinions (during 2008 and 2009) on the safety and efficacy of the additive. The additive was authorised in 2010 as ‘Zinc chelate of hydroxy analogue of methionine’ containing 17.5?18 % zinc, 81 % (2‐hydroxy‐4‐methylthio)butanoic acid (dl‐methionine hydroxy analogue, HMTBa) and maximum 1% mineral oil. Following some modifications in the manufacturing process, the additive does not contain mineral oil and the applicant proposes the following specifications: ≥ 17 % zinc and ≥ 79 % HMTBa. The data provided indicate that the additive complies with the new specifications. No new evidence was found that would make the FEEDAP Panel reconsidering its previous conclusions on the safety for target species, consumers and environment. The applicant provided new studies on the effects of the additive on the respiratory tract and on skin and eyes. Data on the characterisation of the additive and the new studies on skin/eyes led the Panel to reconsider the safety for the user. Owing to the zinc and nickel content of Mintrex?Zn, the handling of the additive poses a risk to users by inhalation; the additive is not a skin or eye irritant but is considered a skin sensitiser. The present application did not include a proposal for amending or supplementing the conditions of the original authorisation that would have an impact on the efficacy of the additive; therefore, there was no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
机译:要求在动物饲料(进料)中使用的添加剂和产品或物质小组提供科学意见,了解甲硫氨酸羟基(Mintrex XN)羟基螯合物锌螯合物授权的申请表达所有动物物种。 COFEP面板在添加剂的安全性和疗效上提供了三种意见(2008年和2009年)。添加剂于2010年被授权为含有17.5〜18%锌,81%(2-羟基-4-甲基硫基)丁酸(DL-甲硫氨酸羟基类似物,HMTBA)和最大1%矿物质油。在制造过程中进行一些修改后,添加剂不含矿物油,申请人提出以下规格:≥17%锌和≥79%HMTBA。提供的数据表明添加剂符合新规格。没有发现任何新的证据将使进纸小组重新考虑其先前关于目标物种,消费者和环境的安全的结论。申请人提供了关于添加剂对呼吸道和皮肤和眼睛的影响的新研究。关于添加剂表征的数据和对皮肤/眼睛的新研究带领小组重新考虑了用户的安全性。由于Mintrex Zn的锌和镍含量,添加剂的处理对用户吸入构成了风险;添加剂不是皮肤或眼睛刺激物,但被认为是皮肤敏感剂。本申请不包括修改或补充原始授权条件的提案,这些授权会影响添加剂的疗效;因此,不需要评估添加剂在授权的续期范围内的疗效。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号